Tsveta Milanova

Tsveta Milanova is the Chief Commercial Officer (CCO) at Agios Pharmaceuticals, a position she has held since January 2023. With over 20 years of experience in the biopharmaceutical industry, she specializes in commercial leadership and global market access.

Professional Background

Before joining Agios, Milanova spent nearly five years at Alexion Pharmaceuticals, where she held several senior vice president roles, including Head of U.S. Commercial and Head of Global Commercial Strategy. Her responsibilities encompassed leading significant commercial operations and market access strategies, particularly in the rare disease sector.

Prior to her tenure at Alexion, she worked for over a decade at Celgene, focusing on global pricing and market access, ultimately serving as the Global Head of Pricing and Market Access for the hematology and oncology division. Her career began with roles at GlaxoSmithKline and Eli Lilly, where she gained foundational experience in health economics and market access.

Education

Milanova holds multiple advanced degrees, including:

• Master of Science (MSc) in Pharmacy from the Medical University of Sofia, Bulgaria.
• Master of Science (MSc) in International Health Policy from the London School of Economics.
• Graduate Diploma in Pharmaceutical Research from the University of Sydney.
• Alumni of Harvard Business School's Advanced Management Program.

Skills and Expertise

Her expertise includes business and commercial strategy, P&L operations, marketing, product launch planning, pricing, and policy shaping. Milanova is recognized as a thought leader in her field, contributing significantly to the commercialization of innovative therapies in the biopharmaceutical sector.1234